Nanogen's Q2 Revenues Rise 22 Percent, Loss Narrows | GenomeWeb
NEW YORK (GenomeWeb News) – Nanogen today reported that total revenues for the second quarter of 2008 grew 25 percent to $12.9 million from $10.3 million in the year-ago period, while its loss fell by 65 percent.
 
Nanogen posted a 51 percent increase in product revenues for the quarter ended June 30, to $8 million from $5.3 million recorded in the comparable period of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.